Effect of Probucol in Lecithin-Cholesterol Acyltransferase–Deficient Mice
- 1 March 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (3) , 394-400
- https://doi.org/10.1161/01.atv.21.3.394
Abstract
Abstract —Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol–fed female mice and in the thyroid gland of the low cholesterol–fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.Keywords
This publication has 24 references indexed in Scilit:
- Selective Down-Regulation by Protein Kinase C Inhibitors of Apolipoprotein-Mediated Cellular Cholesterol Efflux in MacrophagesBiochemistry, 1997
- Apolipoprotein E Produced by Human Monocyte-derived Macrophages Mediates Cholesterol Efflux That Occurs in the Absence of Added Cholesterol AcceptorsJournal of Biological Chemistry, 1996
- Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein ReceptorScience, 1996
- Selective Inhibition of Free Apolipoprotein-Mediated Cellular Lipid Efflux by ProbucolBiochemistry, 1996
- Regulation of Cellular Cholesterol Efflux by Lecithin:Cholesterol Acyltransferase Reaction through Nonspecific Lipid ExchangeJournal of Biological Chemistry, 1996
- Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol effluxBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.Journal of Clinical Investigation, 1995
- Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?Journal of Clinical Investigation, 1994
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986